Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002074127 | SCV002321769 | likely benign | Deficiency of isobutyryl-CoA dehydrogenase | 2022-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541300 | SCV003697536 | uncertain significance | Inborn genetic diseases | 2022-01-26 | criteria provided, single submitter | clinical testing | The c.173G>A (p.R58Q) alteration is located in exon 2 (coding exon 2) of the ACAD8 gene. This alteration results from a G to A substitution at nucleotide position 173, causing the arginine (R) at amino acid position 58 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001796943 | SCV002037443 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001796943 | SCV002037879 | likely benign | not provided | no assertion criteria provided | clinical testing |